M. Okamoto

发表

Ready, willing, and able to provide MTM services?: A survey of community pharmacists in the USA.

A. Law, M. Okamoto, K. Brock, 2009, Research in social & administrative pharmacy : RSAP.

Decision analysis model evaluating the cost-effectiveness of risperidone, olanzapine and haloperidol in the treatment of schizophrenia.

M. Bounthavong, M. Okamoto, M. P. Okamoto, 2007, Journal of evaluation in clinical practice.

Effect of Nesiritide Infusion Duration on Renal Function in Acutely Decompensated Heart Failure Patients

J. Heywood, S. Chow, M. Okamoto, 2007, The Annals of pharmacotherapy.

Effect of antihypertensive formulation on health service expenditures

D. Sclar, L. M. Robison, R. Nakahiro, 1993, Clinical autonomic research : official journal of the Clinical Autonomic Research Society.

Pharmacokinetics of meropenem in patients with intra-abdominal infections

T. Berne, P. Heseltine, J. Farino, 1994, Antimicrobial Agents and Chemotherapy.

Analysis of Cefepime Tissue Penetration Into Human Appendix

T. Berne, P. Heseltine, D. Sclar, 1991, Pharmacotherapy.

Cost-EffectivenessAnalysis of Ondansetron and Prochlorperazine for the Prevention of Postoperative Nausea andVomiting

Jack J. Chen, Peter S. Chang, M. Okamoto, 2005, Journal of managed care pharmacy : JMCP.

Systematic Reviews: Synthesis of Best Evidence for Health Care Decisions

M. Okamoto, 1998 .

Effect of pharmaceutical formulation for antihypertensive therapy on health service utilization.

D. Sclar, L. M. Robison, R. Nakahiro, 1993, Clinical therapeutics.

Evaluation of propofol infusion syndrome in pediatric intensive care.

A. Amin, M. Okamoto, Debra L Kawaguchi, 2003, American Journal of Health-System Pharmacy.

Determination of fluconazole in human serum by solid-phase extraction and reversed-phase high-performance liquid chromatography.

M. Gill, K. Inagaki, E. Lor, 1992, Therapeutic drug monitoring.

Cefepime Clinical Pharmacokinetics

R. Nakahiro, M. Okamoto, A. Chin, 1993, Clinical pharmacokinetics.

Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes.

A. Wong-Beringer, D. Hsu, R. Murthy, 2005, The Journal of antimicrobial chemotherapy.

Intraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue

T. Berne, P. Heseltine, D. Sclar, 1990, Antimicrobial Agents and Chemotherapy.

A randomized study of cefepime versus the combination of gentamicin and meziocillin as an adjunct to surgical treatment in patients with acute cholecystitis

P. Heseltine, M. Appleman, M. Gill, 1994, Surgery, gynecology & obstetrics.

Pharmacoeconomic Evaluation of a Pharmacist‐Managed Hypertension Clinic

Randy Nakahiro, M. Okamoto, M. P. Okamoto, 2001, Pharmacotherapy.

Cefepime: a new fourth-generation cephalosporin.

R. Nakahiro, M. Gill, M. Okamoto, 1994, American journal of hospital pharmacy.

Perceptions of Medicare Part D enrollees about pharmacists and their role as providers of medication therapy management.

A. Law, M. Okamoto, K. Brock, 2008, Journal of the American Pharmacists Association : JAPhA.

ASHP survey of ambulatory care pharmacy practice in health systems--2004.

K. Knapp, B. L. Black, M. Okamoto, 2005, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Prevalence and types of disease management programs in community pharmacies in California.

A. Law, Peter S. Chang, M. Okamoto, 2005, Journal of managed care pharmacy : JMCP.

Effect of health education in promoting prescription refill compliance among patients with hypertension.

D. Sclar, R. Nakahiro, T. Skaer, 1991, Clinical therapeutics.

Cost analysis of cefmetazole versus cefoxitin in the treatment of penetrating abdominal trauma

T. Berne, P. Heseltine, M. Appleman, 1993 .

Utility of a transdermal delivery system for antihypertensive therapy. Part 2.

D. Sclar, T. Skaer, M. Gill, 1991, The American journal of medicine.

Cefepime pharmacokinetics in patients with acute cholecystitis undergoing cholecystectomy.

T. Berne, R. Nakahiro, A. Yellin, 1993, Clinical pharmacy.

Pharmacokinetic population parameters for aminoglycosides in cholecystitis patients.

D. Sclar, R. Nakahiro, M. Gill, 1992, Therapeutic drug monitoring.

Stability of ranitidine hydrochloride with aztreonam, ceftazidime, or piperacillin sodium during simulated Y-site administration.

M. Gill, K. Inagaki, M. Okamoto, 1992, American journal of hospital pharmacy.

Utility of a transdermal delivery system for antihypertensive therapy. Part 1.

D. Sclar, T. Skaer, M. Gill, 1991, The American journal of medicine.